REGEN CONSULTING
ActiveREGEN CONSULTING has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91k and a net result of €2k. Equity is growing by ~22.1% per year across the filed fiscal years. Its solvency ranks better than 92% of 50 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.5% (low).
Checked score
Score 2025
86
/ 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability12▼-88
Solvency100=
Growth52=
Stability94
Bankruptcy probability, 12 months
1.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 7.38 against 3.61 in 2024), and 13.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
86.9%
Return on assets
2.1%
Age of the figures
8 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
35 d early
2024
31 d early
2023
33 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€91k▲ 2.5%
2024 · €88k
2023: €52k
2024: €88k
2023 → 2025
Total assets
€104k▼ 11.2%
2024 · €117k
2023: €79k
2024: €117k
2023 → 2025
Net result
€2k▼ 94.0%
2024 · €37k
2023: €45k
2024: €37k
2023 → 2025
Working capital
€87k▲ 15.5%
2024 · €76k
2023: €27k
2024: €76k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€52k-€88k▲ 71.7%€91k▲ 2.5%
Operating result€58k-€47k▼ 18.3%€4k▼ 90.6%
Net result€45k-€37k▼ 17.1%€2k▼ 94.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 91% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €104k
Fixed assets
€3k▼ 74.2%
Current assets
€101k▼ 3.4%
Equity and liabilities €104k
Equity
€91k▲ 2.5%
Debt
€14k▼ 52.8%
The debt ratio falls from 24.7% to 13.1%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€14k▼
2024 · €57k
Cash flow
€12k▼
2024 · €46k
Solvency
86.9%▲
2024 · 75.3%
Current ratio
7.38▲
2024 · 3.61
Quick ratio
7.38▲
2024 · 3.61
Debt / equity
0.15▼
2024 · 0.33
ROE
2.4%▼
2024 · 41.7%
ROA
2.1%▼
2024 · 31.4%
Interest coverage
211.76▼
2024 · 345.59
Debt
€14k▼
2024 · €29k
Debt ≤ 1 year
€14k▼
2024 · €29k
Income taxes
€2k▼
2024 · €11k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€117k€104k▼
Fixed assets21/28€13k€3k▼
Tangible fixed assets22/27€13k€3k▼
Plant, machinery and equipment23€2k€1k▼
Furniture and vehicles24€10k€2k▼
Financial fixed assets28€250€250=
Current assets29/58€105k€101k▼
Amounts receivable within one year40/41€8k€25k▲
Trade receivables40€8k€24k▲
Other amounts receivable41-€900
Cash at bank and in hand54/58€94k€76k▼
Deferred charges and accrued income490/1€2k€517▼
Equity and liabilities
Total equity and liabilities10/49€117k€104k▼
Equity10/15€88k€91k▲
Contributions10/11€7k€7k=
Capital10-€7k
Issued capital100-€7k
Reserves13€81k€84k▲
Distributable reserves133€81k€84k▲
Amounts payable17/49€29k€14k▼
Amounts payable within one year42/48€29k€14k▼
Trade debts44€3k€389▼
Suppliers440/4€3k€389▼
Taxes, remuneration and social security45€26k€13k▼
Taxes450/3€26k€13k▼
Other amounts payable47/48€138€165▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€9k▲
Other operating charges640/8€507€925▲
Gross operating margin9900€57k€15k▼
Operating profit (loss)9901€47k€4k▼
Financial income75/76B€755€17▼
Recurring financial income75€755€17▼
Financial charges65/66B€164€66▼
Recurring financial charges65€164€66▼
Profit (loss) for the period before taxes9903€48k€4k▼
Income taxes67/77€11k€2k▼
Profit (loss) for the period9904€37k€2k▼
Profit (loss) for the period to be appropriated9905€37k€2k▼
Appropriation of the result
Profit (loss) to be appropriated9906€37k€2k▼
Transfer to equity691/2€37k€2k▼
To other reserves6921€37k€2k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Weakest financial yearnet €2k ▼94%
Net result drops to €2k, the lowest in the series.
31-12
Financial
Liquidity doublescurrent ratio 7.38
Current ratio from 3.61 to 7.38; short-term debt falls from €29k to €14k.
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chaumont-Gistoux · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Gentilsart 21325 Chaumont-GistouxGround area
1.9 ha
Building footprint
423 m²
Volume, LiDAR
2,976 m³
Parcel 25018D0515/00D000, Wallonia · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
REGEN CONSULTING
since 20222.337.078.309
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25018D0515/00D000 | Wallonia | 1.9 ha | 1 · 423 m² | 11.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Pharmacie BIHAIN
BE 0562.948.012
Trois-Ponts · Eq €90k
APR Pharma
BE 0748.905.227
Courcelles · Eq €94k
SHANT LABORATORIES BELGIUM
BE 0466.646.313
Tubize · Eq €96k
CLARETHIS
BE 0894.880.626
Soignies · Eq €86k
SUPERBIOTICS
BE 0719.267.569
Eghezée · Eq €84k
Of 150 companies in sector 21100 we hold annual accounts for 108. 62 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-09-2022
Fiscal year end31-12
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
01471Crop and animal production, hunting and related service activities
47210Retail sale of fruit and vegetables
47810Retail trade
59111Production of cinema films
70200Business and other management consultancy
70220Business consulting
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.